An evaluation of minimal clinically important differences for the initiation of antihypertensive therapy from the perspective of Canadian patients and physicians.

Finlay A. McAlister
Background. Traditional hypertension guidelines from different countries or organizations often specified different treatment thresholds. These discrepancies have enormous public health implication. As the choice of treatment threshold is a utility-sensitive decision, determination of the preferences of practicing physicians and hypertensive patients is important for future policy making. Methods. A survey to determine the minimal clinically important differences (MCIDs) of patients and physicians for the initiation of antihypertensive therapy in the primary prevention of cardiovascular disease....
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.